We are live on
!
Find out more
NanoViricides
NNVC
NNVC
48 hedge funds and large institutions have $1.73M invested in NanoViricides in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
12% more funds holding
Funds holding: 43 → 48 (+5)
5.6% less ownership
Funds ownership: 14.4% → 8.8% (-5.6%)
51% less capital invested
Capital invested by funds: $3.51M → $1.73M (-$1.78M)
Holders
48
Holders Change
+5
Holders Change %
+11.63%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
9
Reduced
3
Closed
8
Calls
$37K
Puts
–
Net Calls
+$37K
Net Calls Change
-$17K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$189K |
| 2 |
Squarepoint
New York
|
+$60.8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$53.4K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$49.4K |
| 5 |
MFS
Miller Financial Services
Marshall,
Michigan
|
+$34.5K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$1.55M |
| 2 |
Jane Street
New York
|
-$105K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$83.6K |
| 4 |
Renaissance Technologies
New York
|
-$40.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$19.4K |
